Page last updated: 2024-08-23

mifepristone and Atypical Endometrial Hyperplasia

mifepristone has been researched along with Atypical Endometrial Hyperplasia in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	5 (83.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akerman, G; Barranger, E; Desfeux, P; Malartic, C; Morel, O; Tulpin, L	1
Bagaria, M; Guleria, K; Mishra, K; Suneja, A; Vaid, NB	1
Jackson, R; Jacoby, AF; Pritts, EA; Steinauer, J	1
Chabbert-Buffet, N; Gelber, H; Grunberg, SM; Lindenberg, T; Sitruk-Ware, R; Spitz, IM	1
Bostedt, H; Breitkopf, M; Hoffmann, B	1
Isacson, C; New, MI; Newfield, RS; Spitz, IM	1

Reviews

2 review(s) available for mifepristone and Atypical Endometrial Hyperplasia

Article	Year
[Role of mifepristone for the treatment of uterine fibroid]. Gynecologie, obstetrique & fertilite, 2008, Volume: 36, Issue:6 Topics: Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Female; Hot Flashes; Humans; Leiomyoma; Liver; Mifepristone; Treatment Outcome; Uterine Neoplasms	2008
Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstetrics and gynecology, 2004, Volume: 103, Issue:6 Topics: Adult; Clinical Trials as Topic; Endometrial Hyperplasia; Female; Hormone Antagonists; Humans; Leiomyoma; Middle Aged; Mifepristone; Uterine Neoplasms	2004

Trials

2 trial(s) available for mifepristone and Atypical Endometrial Hyperplasia

Article	Year
Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial. The Australian & New Zealand journal of obstetrics & gynaecology, 2009, Volume: 49, Issue:1 Topics: Adult; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Female; Follicular Phase; Hormone Antagonists; Humans; Leiomyomatosis; Menorrhagia; Middle Aged; Mifepristone; Placebos; Uterine Neoplasms	2009
Management of patients receiving long-term treatment with mifepristone. Fertility and sterility, 2005, Volume: 84, Issue:6 Topics: Adrenal Insufficiency; Adult; Aged; Aged, 80 and over; Amenorrhea; Drug Monitoring; Endometrial Hyperplasia; Female; Hormone Antagonists; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Mifepristone; Time Factors	2005

Article

Year

Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial.

The Australian & New Zealand journal of obstetrics & gynaecology, 2009, Volume: 49, Issue:1

Topics: Adult; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Female; Follicular Phase; Hormone Antagonists; Humans; Leiomyomatosis; Menorrhagia; Middle Aged; Mifepristone; Placebos; Uterine Neoplasms

2009

Management of patients receiving long-term treatment with mifepristone.

Fertility and sterility, 2005, Volume: 84, Issue:6

Topics: Adrenal Insufficiency; Adult; Aged; Aged, 80 and over; Amenorrhea; Drug Monitoring; Endometrial Hyperplasia; Female; Hormone Antagonists; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Mifepristone; Time Factors

2005

Other Studies

2 other study(ies) available for mifepristone and Atypical Endometrial Hyperplasia

Article	Year
Treatment of pyometra (cystic endometrial hyperplasia) in bitches with an antiprogestin. Journal of reproduction and fertility. Supplement, 1997, Volume: 51 Topics: Animals; Anti-Bacterial Agents; Cysts; Dog Diseases; Dogs; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Mifepristone; Progesterone; Progestins; Receptors, Progesterone	1997
Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia. Clinical endocrinology, 2001, Volume: 54, Issue:3 Topics: Adolescent; Contraceptives, Oral, Synthetic; Cushing Syndrome; Endometrial Hyperplasia; Female; Glucocorticoids; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Mifepristone; Osteoporosis; Progesterone; Uterus	2001